HU
$0.61
+0.01
(+1.51%)
As of Sep 5, 2026, 4:36 PM EDT
Price history
Humacyte Inc (HUMA) is trading up at $0.61 (+1.51%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
Recent News (2)
-
Humacyte plans November FDA filing for dialysis access use
Humacyte plans November FDA filing for dialysis access use
-
Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions – Supplemental Biologics License Application (BLA) expected to be filed with the Food and Drug Administration (FDA) in November 2026 –
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International